Abstract: An ultrasonic wave generation device including: an ultrasonic wave generation source; an ultrasonic wave condensation part; and a waveguide. The ultrasonic wave condensation part has a first reflection surface opposed to the ultrasonic wave generation source and a second reflection surface opposed to the first reflection surface. The first reflection surface reflects the ultrasonic wave, generated from the ultrasonic wave generation source, toward the second reflection surface. The second reflection surface reflects the ultrasonic wave, which has been reflected by the first reflection surface, toward the waveguide so as to introduce the ultrasonic wave into the waveguide. The waveguide protrudes from the first reflection surface to a side opposite the second reflection surface. A recessed portion is formed from the first reflection surface to the second reflection surface side along an outer circumferential surface of the waveguide.

Abstract: A plasma irradiation apparatus includes: a gas guide channel defining therein a flow path for flow of a discharge gas, with an outlet port formed at an end of the flow path; and a discharge section that generates plasma discharge in the gas guide channel. The plasma irradiation apparatus is mounted to a distal device which is movable relative to a target substance. The plasma irradiation apparatus further includes a valve arranged in the gas guide channel or a gas supply channel and configured as a valve capable of changing a flow rate of the discharge gas according to an opening degree of the valve or as a check valve.

Abstract: A plasma irradiation apparatus has a gas guide channel and a creeping discharge section. The creeping discharge section is disposed such that one of a discharge electrode and a ground electrode faces a flow path directly or via another member, and is configured to generate creeping discharge in the flow path by the application of a periodically changing voltage to the discharge electrode. At least a part of the ground electrode is arranged closer to an outlet port than the discharge electrode.

Abstract: A plasma irradiation device has a gas flow channel and an electric field generation section and is provided in a handpiece. The gas flow channel is a flow channel for supplying a gas from the outside of the handpiece to a distal end portion of the acting member. The electric field generation section has a first electrode portion, a second electrode portion, and a dielectric member and is disposed in the gas flow channel. The electric field generation section generates an electric field in a space within the gas flow channel by using a potential difference between the first electrode portion and the second electrode portion, thereby producing low-temperature plasma discharge.

Abstract: Provided is a plasma reactor capable of reliably generating plasma even in the event of inflow of water. The plasma reactor of the present invention includes a plasma panel stack 20, electrically conductive members 51 and 54, a case, and a mat 71. The plasma panel stack 20 has a structure in which electrode panels 30 are stacked, and generates plasma upon application of voltage between the adjacent electrode panels 30. The electrically conductive members 51 and 54 are electrically connected to discharge electrodes of the electrode panels 30. The case houses the plasma panel stack 20. The mat 71 intervenes between the case and the plasma panel stack 20 and fixes the plasma panel stack 20 to the case. The mat 71 is disposed apart from the electrically conductive members 51 and 54 so that gaps S1 and S2 are formed between the mat 71 and the electrically conductive members 51 and 54, respectively.

Abstract: Provided is a plasma reactor capable of reliably generating plasma even in the event of inflow of water. The plasma reactor of the present invention includes a plasma panel stack 20, electrically conductive members 51 and 54, a case, and a mat 71. The plasma panel stack 20 has a structure in which electrode panels 30 are stacked, and generates plasma upon application of voltage between the adjacent electrode panels 30. The electrically conductive members 51 and 54 are electrically connected to discharge electrodes of the electrode panels 30. The case houses the plasma panel stack 20. The mat 71 intervenes between the case and the plasma panel stack 20 and fixes the plasma panel stack 20 to the case. The mat 71 is disposed apart from the electrically conductive members 51 and 54 so that gaps S1 and S2 are formed between the mat 71 and the electrically conductive members 51 and 54, respectively.

Abstract: A server includes a terminal information acquisition unit, a region specifying unit, and a distribution information generation unit. The terminal information acquisition unit acquires from each of a plurality of first terminal devices, terminal information including measurement information used to calculate a distance from each of second terminal devices to each of the plurality of first terminal devices for each second terminal device present near the first terminal device and position information of the first terminal device. The region specifying unit specifies a region in which the second terminal device is disposed at a distance according to the measurement information from the position of each of the first terminal devices. The distribution information generation unit generates the information indicating the distribution of the positions of the first terminal device and the second terminal device based on the region specified by the region specifying unit.

Abstract: A guiding server according to this application includes an image storing unit, a retrieving unit, and a generating unit. The image storing unit stores a signboard image of a signboard. The retrieving unit retrieves, from the image storing unit, a signboard image of a signboard on a way to a destination based on location information and destination information of a user terminal. The generating unit generates guiding information including the signboard image based on the retrieved signboard image, the location information and the destination information and transmits the guiding information to the user terminal.

Abstract: A terminal apparatus provides a highly convenient user interface. The terminal apparatus includes a designated direction detection unit and a display control unit. The designated direction detection unit detects a designated direction, which is a direction in which the terminal apparatus is directed, with respect to a reference direction as a reference of the direction of the terminal apparatus on the basis of a signal from a sensor that outputs a signal indicating the attitude of the terminal apparatus. The display control unit displays an image, in which the direction in which the object is directed with respect to the reference direction is maintained and the object is disposed at the end of a direction corresponding to the designated direction, on a display device.

Abstract: The present invention is to create a compound that selectively activates glucokinase in the liver, and in particular, to provide an agent for treating and preventing diabetes and impaired glucose tolerance, wherein the agent has a low hypoglycemia risk. A compound represented by the formula (1) as shown below, or a salt thereof, or a solvate of the compound or the salt: wherein, in the following formula (1), ring A represents a thiazolyl group, a pyridyl group, a pyrazyl group, or a pyrazolyl group; L represents —(CO)—, —(CS)—, or —SO2—; and R1 represents a C1-6 alkyl group, a hydroxy C1-6 alkyl group, a C1-6 alkoxy group, an amino group, a C1-6 alkylamino group, a hydroxyamino group, an N—C1-6 alkylcarbamoyl group, or a group represented by the formula (2) as shown below, wherein R3 represents a C1-6 alkyl group; and R2 represents a hydrogen atom, a halogen atom, a C1-6 alkyl group, a C1-6 alkoxy group, or a carboxyl group.

Abstract: The present invention is to create a compound that selectively activates glucokinase in the liver, and in particular, to provide an agent for treating and preventing diabetes and impaired glucose tolerance, wherein the agent has a low hypoglycemia risk. A compound represented by the formula (1) as shown below, or a salt thereof, or a solvate of the compound or the salt: [wherein, in the following formula (1), ring A represents a thiazolyl group, a pyridyl group, a pyrazyl group, or a pyrazolyl group; L represents —(CO)—, —(CS)—, or —SO2—; and R1 represents a C1-6 alkyl group, a hydroxy C1-6 alkyl group, a C1-6 alkoxy group, an amino group, a C1-6 alkylamino group, a hydroxyamino group, an N—C1-6 alkylcarbamoyl group, or a group represented by the formula (2) as shown below, wherein R3 represents a C1-6 alkyl group; and R2 represents a hydrogen atom, a halogen atom, a C1-6 alkyl group, a C1-6 alkoxy group, or a carboxyl group].

Abstract: The present invention is a method for producing a plastic lens, containing polymerizing a monomer composition, at least one compound selected from a compound represented by the following formula (1) and a compound represented by the following formula (2) being added in polymerization of the monomer composition: wherein in the formulae (1) and (2), one of X1 and X2 represents a chlorine atom, and the other thereof represents a hydrogen atom; and R1 and R2 each independently represent a hydrogen atom or a group selected from an alkyl group having from 1 to 8 carbon atoms.

Abstract: A server includes a terminal information acquisition unit, a region specifying unit, and a distribution information generation unit. The terminal information acquisition unit acquires from each of a plurality of first terminal devices, terminal information including measurement information used to calculate a distance from each of second terminal devices to each of the plurality of first terminal devices for each second terminal device present near the first terminal device and position information of the first terminal device. The region specifying unit specifies a region in which the second terminal device is disposed at a distance according to the measurement information from the position of each of the first terminal devices. The distribution information generation unit generates the information indicating the distribution of the positions of the first terminal device and the second terminal device based on the region specified by the region specifying unit.

Abstract: A terminal apparatus provides a highly convenient user interface. The terminal apparatus includes a designated direction detection unit and a display control unit. The designated direction detection unit detects a designated direction, which is a direction in which the terminal apparatus is directed, with respect to a reference direction as a reference of the direction of the terminal apparatus on the basis of a signal from a sensor that outputs a signal indicating the attitude of the terminal apparatus. The display control unit displays an image, in which the direction in which the object is directed with respect to the reference direction is maintained and the object is disposed at the end of a direction corresponding to the designated direction, on a display device.

Abstract: The present invention provides a novel compound represented by a general formula (1) as shown below, which has a glucokinase-activating action in the liver and pancreatic ?-cells and which is useful as an agent for preventing and/or treating diseases caused by hyperglycemia, such as diabetes. A spiroindoline compound represented by the general formula (1), or a salt thereof, or a solvate of the compound or the salt: [wherein ring A represents a nitrogen-containing 5-10 membered heteroaryl group; R1 and R2, which are the same or different, each represent a hydrogen atom, a halogen atom, a halo C1-6 alkyl group, a C6-10 aryl group, a cyano group, a C1-6 alkyl group optionally having a substituent, a C2-6 alkenyl group optionally having a substituent, etc.; R3 represents a hydrogen atom, a C1-6 alkyl group optionally having a substituent, etc.; and R4 represents a hydrogen atom, a halogen atom, a C1-6 alkyl group optionally having a substituent, etc.

Abstract: A plastic lens having excellent weather resistance, formed by polymerization of a composition containing a polyisocyanate compound having an aromatic ring and a polythiol compound is provided. The plastic lens is formed by polymerization of a composition that contains 100 parts by mass in total of (A) a polyisocyanate compound containing a polyisocyanate compound having an aromatic ring and (B) a polythiol compound, from 0.5 to 5.0 parts by mass of (C) a benzophenone compound having a hydroxyl group on at least the ortho position, and from 0.5 to 5.0 parts by mass of (D) a phenol compound.

Abstract: Provided is compound for improving blood flow at sites of impaired circulation in the extremities, through promoting development of collateral blood circulation without angiogenesis; also provided is a therapeutic agent for sensitivity to cold or cold sensation, in which the active ingredient is a compound for improving blood flow at sites of impaired circulation in the extremities. A collateral blood flow development promoter, in which the active ingredient is (?)-6-[3-[3-cyclopropyl-3-[(1R,2R)-2-hydroxycyclohexyl]ureido]propoxy]-2(1H)-quinolinone or a salt thereof, or a solvate thereof.

Abstract: The present invention is a method for producing a plastic lens, containing polymerizing a monomer composition, at least one compound selected from a compound represented by the following formula (1) and a compound represented by the following formula (2) being added in polymerization of the monomer composition: wherein in the formulae (1) and (2), one of X1 and X2 represents a chlorine atom, and the other thereof represents a hydrogen atom; and R1 and R2 each independently represent a hydrogen atom or a group selected from an alkyl group having from 1 to 8 carbon atoms.

Abstract: The present invention provides a novel compound represented by a general formula (1) as shown below, which has a glucokinase-activating action in the liver and pancreatic ?-cells and which is useful as an agent for preventing and/or treating diseases caused by hyperglycemia, such as diabetes. A spiroindoline compound represented by the general formula (1), or a salt thereof, or a solvate of the compound or the salt: [wherein ring A represents a nitrogen-containing 5-10 membered heteroaryl group; R1 and R2, which are the same or different, each represent a hydrogen atom, a halogen atom, a halo C1-6 alkyl group, a C6-10 aryl group, a cyano group, a C1-6 alkyl group optionally having a substituent, a C2-6 alkenyl group optionally having a substituent, etc.; R3 represents a hydrogen atom, a C1-6 alkyl group optionally having a substituent, etc.; and R4 represents a hydrogen atom, a halogen atom, a C1-6 alkyl group optionally having a substituent, etc.

Abstract: A guiding server according to this application includes an image storing unit, a retrieving unit, and a generating unit. The image storing unit stores a signboard image of a signboard. The retrieving unit retrieves, from the image storing unit, a signboard image of a signboard on a way to a destination based on location information and destination information of a user terminal. The generating unit generates guiding information including the signboard image based on the retrieved signboard image, the location information and the destination information and transmits the guiding information to the user terminal.